LDN: Assessing Auditory Sensory Memory Capabilities in CLN3 Disease as a Biomarker for Neurocognitive Decline
Mar 22, 2024 ·
2m 1s
New research from the Lysosomal Disease Network (LDN). This summary is based on a paper published in the Journal of Neurodevelopmental Disorders on January 6, 2024, titled "Assessing the integrity...
show more
New research from the Lysosomal Disease Network (LDN). This summary is based on a paper published in the Journal of Neurodevelopmental Disorders on January 6, 2024, titled "Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN)."
Read the paper here: https://jneurodevdisorders.biomedcentral.com/articles/10.1186/s11689-023-09515-8
Learn more about LDN: https://ldn.rarediseasesnetwork.org
show less
Read the paper here: https://jneurodevdisorders.biomedcentral.com/articles/10.1186/s11689-023-09515-8
Learn more about LDN: https://ldn.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
